April 16th 2024
The 5-in-1 vaccine candidate has the potential to reduce shots and simplify the immunization process.
April 15th 2024
The monoclonal antibody was approved by the FDA on July 17, 2023 and quickly saw high demand at the onset of the RSV season.
April 9th 2024
A study on Italian vaccination rates and factors influencing Rotavirus vaccine acceptance.
April 5th 2024
Of the 600,238 bivalent vaccine doses administered by all providers in the study period, 35,114 (5.9%) were done so by FRPP partners.
April 2nd 2024
New data demonstrates protection against new variants.